{"transactions":[{"id":739307,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:25.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":77000,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001568850-26-000002","document":"form4-06122026_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000156885026000002/form4-06122026_040607.xml","form_type":"4"}},{"id":1112968,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:19:08.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-016931","document":"form4-06122025_040608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925016931/form4-06122025_040608.xml","form_type":"4"}},{"id":1419772,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-29T20:15:14.000Z","date":"2024-08-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on September 28, 2024, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.45,"expiration_date":"2034-08-28","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-022534","document":"form4-08292024_040806.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588924022534/form4-08292024_040806.xml","form_type":"4"}},{"id":1476898,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-17T17:07:05.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1) 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 13, 2025 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":1.12,"expiration_date":"2025-06-13","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-24-074365","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568850/000095017024074365/ownership.xml","form_type":"4"}},{"id":1624735,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-22T14:22:42.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":35715,"price":1.4,"value":50001.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":35815,"source":{"system":"sec-edgar","filing":"0001209191-24-003785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568850/000120919124003785/doc4.xml","form_type":"4"}},{"id":1853889,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T17:13:06.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 13, 2024 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":2.01,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-037420","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568850/000120919123037420/doc4.xml","form_type":"4"}},{"id":1860145,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-09T20:21:04.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 7, 2023, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.86,"expiration_date":"2033-06-07","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-035836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919123035836/doc4.xml","form_type":"4"}},{"id":2187861,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-11T22:01:22.000Z","date":"2022-07-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on August 5, 2022, provided that the option will in any case be fully vested\non the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each\nsuch vesting date."}],"balance_after":30000,"derivative":{"exercise_price":6.07,"expiration_date":"2032-07-05","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-045471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919122045471/doc4.xml","form_type":"4"}},{"id":2226725,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T16:18:06.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":41841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2023 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date."}],"balance_after":41841,"derivative":{"exercise_price":2.39,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":41841},"source":{"system":"sec-edgar","filing":"0001209191-22-037849","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568850/000120919122037849/doc4.xml","form_type":"4"}},{"id":2532582,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-10-28T17:12:08.000Z","date":"2021-10-26","kind":"grant","acquired":true,"shares":37037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will fully vest on October 26, 2022."}],"balance_after":37037,"derivative":{"exercise_price":2.7,"expiration_date":"2031-10-25","underlying":"Common Stock","underlying_shares":37037},"source":{"system":"sec-edgar","filing":"0001209191-21-061922","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568850/000120919121061922/doc4.xml","form_type":"4"}},{"id":2621958,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-29T21:35:56.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 14, 2021, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":5.54,"expiration_date":"2031-06-14","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-048565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919121048565/doc4.xml","form_type":"4"}},{"id":2741977,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T13:55:57.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":19062,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Merger Agreement provides that each Option granted pursuant to a Company Plan, whether vested or unvested, that is outstanding immediately prior to the Merger Effective Time, will automatically (i) be accelerated and vest in full and (ii) to the extent not exercised prior to the Merger Effective Time, be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any such canceled Option will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of (a) the number of Shares subject to such Option multiplied by (b) the excess, if any, of the Offer Price over the exercise price per Share under such Option; provided that, if the exercise price per Share of any such Option is equal to or greater than the Offer Price, then such Option will be canceled without any cash payment being made in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":13.17,"exercise_date":"2019-02-19","expiration_date":"2025-02-19","underlying":"Common Stock","underlying_shares":19062},"source":{"system":"sec-edgar","filing":"0001487371-21-000182","document":"wf-form4_161911413636920.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000182/wf-form4_161911413636920.xml","form_type":"4"}},{"id":2741976,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-22T13:55:57.000Z","date":"2021-04-22","kind":"other","acquired":false,"shares":5500,"price":24.05,"value":132275.0,"ownership":{"direct":false,"nature":"Lisa M Giles Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated March 12, 2021, by and among Roche Holdings, Inc., a Delaware corporation (\"Parent\"), Geronimo Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (\"Purchaser\"), and GenMark Diagnostics, Inc., a Delaware corporation (the \"Company\") (the \"Merger Agreement\" and the transactions contemplated thereby, the \"Merger\"), whereby Parent caused Purchaser to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $24.05 per share (the \"Offer Price\"). On April 22, 2021 (the \"Merger Effective Time\"), the Company irrevocably accepted for payment all shares that were validly tendered and not withdrawn."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Ms. Giles is the trustee of the Lisa M Giles Living Trust and has voting and dispositive power with respect to these shares. Ms. Giles disclaims beneficial ownership except to the extent of her pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001487371-21-000182","document":"wf-form4_161911413636920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000182/wf-form4_161911413636920.xml","form_type":"4"}},{"id":2741975,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-22T13:55:57.000Z","date":"2021-04-22","kind":"other","acquired":false,"shares":81572,"price":24.05,"value":1961806.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated March 12, 2021, by and among Roche Holdings, Inc., a Delaware corporation (\"Parent\"), Geronimo Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (\"Purchaser\"), and GenMark Diagnostics, Inc., a Delaware corporation (the \"Company\") (the \"Merger Agreement\" and the transactions contemplated thereby, the \"Merger\"), whereby Parent caused Purchaser to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $24.05 per share (the \"Offer Price\"). On April 22, 2021 (the \"Merger Effective Time\"), the Company irrevocably accepted for payment all shares that were validly tendered and not withdrawn."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 21,607 RSUs. The Merger Agreement provides that each RSU awarded pursuant to any Company Plan, whether vested or unvested, that is outstanding immediately prior to the Merger Effective Time, will automatically (i) be fully accelerated and vest in full and the restrictions thereon shall lapse and (ii) be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any such RSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001487371-21-000182","document":"wf-form4_161911413636920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000182/wf-form4_161911413636920.xml","form_type":"4"}},{"id":2846134,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T18:09:16.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":7782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2020 Equity Incentive Plan, which vest in full on June 1, 2022."}],"balance_after":81572,"source":{"system":"sec-edgar","filing":"0001487371-21-000049","document":"wf-form4_161377614019452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000049/wf-form4_161377614019452.xml","form_type":"4"}},{"id":3012562,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-05T22:01:06.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in equal monthly installments, beginning on November 1, 2020, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":7.1,"expiration_date":"2030-10-01","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-053839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120053839/doc4.xml","form_type":"4"}},{"id":3126968,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-02T17:47:38.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":13825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2020 Equity Incentive Plan, which vest in full on the first anniversary of the grant date."}],"balance_after":73790,"source":{"system":"sec-edgar","filing":"0001487371-20-000191","document":"wf-form4_159113443734176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000191/wf-form4_159113443734176.xml","form_type":"4"}},{"id":3383545,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-01T16:49:32.000Z","date":"2019-10-30","kind":"grant","acquired":true,"shares":528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan in connection with her appointment as Chair of the Compensation Committee of the Issuer's Board of Directors, which vest in full on the first anniversary of the grant date."}],"balance_after":59965,"source":{"system":"sec-edgar","filing":"0001487371-19-000224","document":"wf-form4_157264135683356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000224/wf-form4_157264135683356.xml","form_type":"4"}},{"id":3449173,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-02T17:20:41.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan in connection with her appointment as a member of the Compensation Committee of the Issuer's Board of Directors, which vest in full on the first anniversary of the grant date."}],"balance_after":59437,"source":{"system":"sec-edgar","filing":"0001487371-19-000170","document":"wf-form4_156478082472058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000170/wf-form4_156478082472058.xml","form_type":"4"}},{"id":3502274,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T16:18:01.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":17937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan, which vest in full on the first anniversary of the grant date."}],"balance_after":58735,"source":{"system":"sec-edgar","filing":"0001487371-19-000161","document":"wf-form4_155967946639986.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000161/wf-form4_155967946639986.xml","form_type":"4"}},{"id":3915431,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T19:01:01.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":17107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan, which vest in full on the first anniversary of the grant date."}],"balance_after":40798,"source":{"system":"sec-edgar","filing":"0001487371-18-000126","document":"wf-form4_152763484727191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000126/wf-form4_152763484727191.xml","form_type":"4"}},{"id":4301259,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T18:41:49.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":6981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The amount reported reflects restricted stock units granted to the reporting person pursuant to the Issuer's 2010 Equity Incentive Plan, which vest in full on the first anniversary of the grant date."}],"balance_after":23691,"source":{"system":"sec-edgar","filing":"0001487371-17-000125","document":"wf-form4_149618409366068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000125/wf-form4_149618409366068.xml","form_type":"4"}}]}